Stanford University
Showing 25,491-25,500 of 34,414 Results
-
Jessica Rose
Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Rose's research investigates neuromuscular mechanisms underlying cerebral palsy (CP) and early brain and motor development in preterm children. Research examines gait biomechanics as well as neonatal brain microstructure on DTI, physiology and motor function in CP. Dr. Rose served on NIH Taskforce on Childhood Motor Disorders, AACPDM Research Committee, NIH Steering Committee on CDE for CP neuroimaging diagnostics, BOD of SBMT and serves on the IAACD Research Committee.
-
Kevin Rose
Postdoctoral Scholar, Structural Biology
Current Research and Scholarly InterestsI am interested in studying organelle dysfunction and host cell responses at the highest resolution possible in natively preserved tissues. To do this, I couple correlative light and cryo-Electron Tomography (cryo-ET) and perform ultrastructural analysis of healthy and diseased organelles. This technique hopes to uncover new molecular details of pathophysiology so that we can improve our understanding of diseases such as cancer and neurodegeneration to improve the rationale therapeutic design.
-
Sherri Rose
Professor of Health Policy and, by courtesy, of Computer Science
BioSherri Rose, Ph.D. is a Professor of Health Policy and, by courtesy, of Computer Science at Stanford University, where she is Director of the Health Policy Data Science Lab. Her research is centered on developing and integrating innovative statistical machine learning approaches to improve human health. Within health policy, Dr. Rose works on algorithms in health care, risk adjustment, chronic kidney disease, and health program evaluation. She has published interdisciplinary projects across varied outlets, including Biometrics, Journal of the American Statistical Association, Journal of Health Economics, Health Affairs, and New England Journal of Medicine. In 2011, Dr. Rose coauthored the first book on machine learning for causal inference, with a sequel text released in 2018.
Dr. Rose has been honored with an NIH Director’s Pioneer Award, NIH Director's New Innovator Award, the ISPOR Bernie J. O'Brien New Investigator Award, and multiple mid-career awards, including the Gertrude M. Cox Award. She is a Fellow of the American Statistical Association (ASA) and received the Mortimer Spiegelman Award, which recognizes the statistician under age 40 who has made the most significant contributions to public health statistics. In 2024, she received both the ASHEcon Willard G. Manning Memorial Award for Best Research in Health Econometrics and the ASA Outstanding Statistical Application Award. She was recently awarded the Open Science Champion Prize by Stanford University. Her research has been featured in The New York Times, USA Today, and The Boston Globe. She was Co-Editor-in-Chief of the journal Biostatistics from 2019-2023. -
Jennifer Rose-Nussbaumer
Alan Adler Global Ophthalmology Professor
BioDr. Jennifer Rose-Nussbaumer is a board-certified ophthalmologist and fellowship-trained cornea specialist at the Byers Eye Institute at Stanford University. Her clinical practice focuses on corneal transplantation, complex cataract surgery, and the treatment of infectious keratitis.
After completing her fellowship in Cornea and External Disease at the University of California, San Francisco (UCSF), Dr. Rose-Nussbaumer joined the faculty there and remained until 2021, when she transitioned to Stanford. What she loves most about medicine is caring for individual patients—building relationships, understanding each person's unique needs, and guiding them through their treatment with compassion and personalized attention.
In addition to her clinical work, Dr. Rose-Nussbaumer is an NIH-funded physician-scientist whose research centers on randomized clinical trials in ophthalmology. Her research is deeply rooted in her clinical practice: she is passionate about identifying the important, unanswered questions that arise while caring for patients, designing rigorous clinical trials to find the answers, and bringing that new knowledge back to the bedside to improve patient care.
She is the Principal Investigator on a UG1 grant supporting the **Descemet Endothelial Thickness Comparison Trial (DETECT)**, a randomized clinical trial comparing ultra-thin DSAEK (UT-DSAEK) to DMEK, and ripasudil to placebo, in patients with endothelial disease such as Fuchs Endothelial Dystrophy. She is also Principal Investigator on the **Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II)**, a randomized clinical trial conducted in collaboration with Aravind Eye Hospital in India and the University of São Paulo, evaluating the benefit of adjunctive topical steroids, corneal crosslinking, and rose bengal photodynamic therapy in the treatment of infectious corneal ulcers.
A native of Northern California, Dr. Rose-Nussbaumer enjoys spending time with her family and their Bernese Mountain Dog, Kenji, exploring the state's natural beauty through hiking and camping.
